Supply Chain Challenges with New Therapies

July 07, 2016

Supply chains for many regenerative therapies can be very complex. Where traditional pharmaceuticals have linear supply chain models, autologous cell therapies oftentimes require circular supply chains, with little room for error. Tamie Joeckel, senior vice president, client services and consulting, discusses comprehensive strategies used to mitigate risk and manage cold chain complexities. Read more >

Questions or comments? We welcome your feedback!

Email Us

Tags: Clinical Trials Logistics, Temperature Controlled Logistics

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC